Journal of Endocrinological Investigation , 26 (3), 211215
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for three primary indications: type 2 diabetes mellitus, chronic weight management, and cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease
She obtained her BSN in Nursing in 2007 and her MSN in 2011, both from the University of Texas Health Science Center in Houston
doi: 10.1093/chemse/bjp054, 33
Headloss Monitoring: Headloss is the pressure difference between the influent and effluent sides of the BAC filter
Phage-based nanocarriers, probiotic-loaded hydrogels, and antimicrobial peptides integrated into smart biomaterials represent promising avenues to restore microbial balance, suppress infection, and promote tissue regeneration in DFUs [69]